Evidence map›Paper›PMID 21859767›Full record

ArticleBrain : a journal of neurology2011

Treatment of Leber hereditary optic neuropathy.

Nancy J Newman

Registry-linked trialAbstract readComment
In one paragraph

Article in Brain : a journal of neurology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01267422 (Safety and Efficacy Study of a Single Intravitreal Injection of rAAV2-ND4 Treatment of Leber Hereditary Optic Neuropathy), which is not on this map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01267422 nacompletednot on this map

Safety and Efficacy Study of a Single Intravitreal Injection of rAAV2-ND4 Treatment of Leber Hereditary Optic Neuropathy

TypeinterventionalSponsorBin LiRan2011 to 2015Enrolled9ConditionsLeber Hereditary Optic NeuropathyArmsrAAV2-ND4
3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Leber hereditary optic neuropathy-new insights and old challenges.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2021
    Review
  5. Leber's hereditary optic neuropathy: course of disease in consideration of idebenone treatment and type of mutation.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2021
    Observational
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Treatment of hereditary optic neuropathies.Nature reviews. Neurology · 2012
    Review
  13. [Bilateral visual deterioration in excessive tobacco and alcohol consumption].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2012
    Article
  14. [Leber's hereditary optic neuropathy].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2011
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Nancy J NewmanDepartment of Ophthalmology, Emory University, Atlanta, GA, USA. ophtnjn@emory.edu

Funding

P30-Core Grant for Vision Research Core CP30EY006360 · NEI · EMORY UNIVERSITY · PI BOATRIGHT, JEFFREY H · 1986 to 2025
$15.3M
NEI NIH HHS P30 EY006360NEI NIH HHS P30 EY06360
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

PlacebosAntioxidantsFemaleHumansMaleOptic Atrophy, Hereditary, LeberUbiquinoneAntioxidantsidebenonePlacebosUbiquinone

Identifiers

PMID21859767
PMCPMC3202309

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.